The Effect of CUGP Fluid Management in Patients With Sepsis or Septic Shock (NCT06879249) | Clinical Trial Compass
CompletedNot Applicable
The Effect of CUGP Fluid Management in Patients With Sepsis or Septic Shock
China118 participantsStarted 2025-04-01
Plain-language summary
This study aims to assess whether procedural critical ultrasonography guided precise fluid management (CUGP) can affect the clinical fluid management strategy and improve the outcomes of patients with sepsis or septic shock.
Who can participate
Age range18 Years
SexALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* 1\. Age ≥ 18 years old;
* 2\. Estimated length of ICU stay ≥ 24 hours;
* 3\. Diagnosis according to the Sepsis 3.0 criteria, which included:
* a. suspected or confirmed infections supported by clinical evidence and/or positive microbiological findings;
* b. the sepsis related organ failure assessment (SOFA) score ≥ 2.
Exclusion Criteria:
* 1\. Patients were pregnant woman;
* 2\. Patients had acute coronary syndrome;
* 3\. Patients had acute pulmonary edema;
* 4\. Patients had status asthmatics;
* 5\. Patients had malignant arrhythmia;
* 6\. Patients had active gastrointestinal bleeding;
* 7\. Patients had epileptic seizure;
* 8\. Patients had drug poisoning;
* 9\. Patients had severe burns;
* 10\. Patients had contraindications of blood transfusion;
* 11\. Patients had intra-abdominal hypertension (intra-abdominal pressure increases continuously ≥ 12mmHg);
* 12\. Patients had acute pulmonary embolism;
* 13\. Patients had contraindications of leg raising;
* 14\. Patients had cardiac structural or functional abnormalities (left ventricular outflow tract obstruction, moderate-to-severe mitral regurgitation, aortic regurgitation), it would seriously affect the velocity time integral of left ventricular outflow tract;
* 15\. Patients or their legal representatives refused active treatment;
* 16\. Patients or their legal representatives refused to participate in this study;
* 17\. Patients were participating in other interventional clinical trials.